预测HbA1c治疗反应的预测者在甲福明单一治疗后补充药物治疗:基于人口的队列研究
Wei Ying Tan1, Wynne Hsu2,3, Mong Li Lee2,3
1Saw Swee Hock School of Public Health, National University of Singapore, MD1 - Tahir Foundation Building, 12 Science Drive 2, #11, Singapore, 117549, Singapore. tanweiying@u.nus.edu.
Scientific reports
|November 28, 2023
概括
患者的特征,如高血压和高密度胆固醇,影响2型糖尿病 (T2D) 药物反应. 了解这些因素有助于个性化补充疗法 (硫尿素,DPP-4,SGLT-2抑制剂) 以更好地控制HbA1c和预防并发症.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 2型糖尿病 (T2D) 的管理往往需要添加治疗对甲.
- 对常见的附加药物治疗反应的预测因素,如硫尿素 (SU),二乙酶-4 (DPP-4),和-葡萄糖共传递剂-2 (SGLT-2) 抑制剂,尚未完全理解.
- 个性化医疗方法对于优化血糖控制和预防T2D并发症至关重要.
研究的目的:
- 研究患者特征,预测 HbA1c 治疗对 SU,DPP-4 和 SGLT-2 抑制剂补充疗法的反应,在接受甲福林治疗的 T2D 患者中.
- 确定与实现显著的HbA1c降低或目标实现相关的特定的人口,临床和并发症因素.
- 根据个体患者的个人资料,为选择最佳补充药物的临床决策提供信息.
主要方法:
- 使用来自新加坡六家初级保健诊所的电子健康记录进行的回顾性队列研究.
- 倾向性得分匹配 (1:1) 用于比较接受SU,DPP-4或SGLT-2抑制剂的患者与接受其他附加药物的患者.
- 多次逻辑回归分析确定了与HbA1c降低 (6个月≥1%) 和HbA1c目标实现 (12个月<7%) 相关的患者特征.
主要成果:
- 较长的高血压持续时间和较高的HDL胆固醇预测了更好的SU反应.
- 较低的估计膜过率 (eGFR) 和使用血管酶二受体抑制剂预测了更好的DPP-4反应.
- 较低的HDL胆固醇,较高的血清肌素,缺少脏并发症,以及β-阻断剂的使用预测了更好的SGLT-2抑制剂反应.
结论:
- 患者特异性因素包括脂质特征,功能 (eGFR,肌素),高血压史和同时服用的药物显著影响HbA1c治疗对SU,DPP-4和SGLT-2抑制剂的反应.
- 这些发现支持在T2D管理中量身定制补充药物选择.
- 个性化选择附加疗法可以改善血糖控制,并可能减少与糖尿病相关的并发症.
相关概念视频
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
209
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
209
01:22Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
01:15Diabetes: Management and Pharmacotherapy
289
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
289
01:23Dipeptidyl Peptidase 4 Inhibitors
190
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
190
01:36Carbohydrate Metabolism
11.2K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.2K
01:16Insulin: Dosing Regimen and Adverse Effects
181
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
181